WebOct 13, 2024 · New technological development is helping scientists recreate condensates in laboratory conditions, providing insight into fundamental cellular processes. Amir Nashat, CEO of Dewpoint Therapeutics, told In Vivo that the company, following a recent $77m series B round, now has the resources to get to proof of concept for drugs targeting ... WebApr 13, 2024 · Dewpoint Therapeutics translates condensate biology into much-needed medicines. Biomolecular condensates are transforming our understanding of biology, and our highly collaborative team is at the forefront of efforts to harness this shift for drug discovery. Together, we are leveraging a transformative shift in the understanding of …
Dewpoint Therapeutics partners with Novo Nordisk to explore …
WebVolastra Therapeutics and Dewpoint Therapeutics Partner to Discover Novel Condensate Modulators for Cancer Treatment NEW YORK and BOSTON, March 9, 2024 /PRNewswire/ -- Volastra Therapeutics and Dewpoint Therapeutics today announced a research and development partnership to discover novel modulators of biomolecular condensates to … WebDec 20, 2024 · Dewpoint scientists work in Boston, Dresden, and Berlin to translate condensate biology into treatments for the toughest diseases. Learn more at … optimus alarm clock
Scientist/Sr. Scientist - Cheminformatics (m/f/d) - Condensates
WebDewpoint Therapeutics 6,533 followers on LinkedIn. Dewpoint is translating condensate biology into medicine. Dewpoint is the first company to apply the emerging understanding of biomolecular ... WebVolastra Therapeutics and Dewpoint Therapeutics Partner to Discover Novel Condensate Modulators for Cancer Treatment NEW YORK and BOSTON, March 9, 2024 … WebMar 22, 2024 · Dewpoint Therapeutics today announced a research and development partnership with Novo Nordisk to identify drug candidates using Dewpoint's discovery … optimus 4200p instantaneous water heater